Financings in Brief: PolyMedica
This article was originally published in The Gray Sheet
Executive Summary
PolyMedica: Wound dressing, catheter kit, and polyurethane materials firm announces a public offering of 700,000 shares, to be sold through Jefferies & Company and Rodman & Renshaw for $6.50 each. Proceeds will fund "research and development, the promotion of new products, the acquisition of related or complementary businesses or products and other general corporate purposes," the Woburn, Massachusetts-based firm says...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.